Schwarzenbach H. Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma. Med Oncol 2002;19:87–104.
CAS
Article
PubMed
Google Scholar
Chai S, To KK, Lin G. Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines. Chin Med 2010;5:26.
Article
PubMed
PubMed Central
Google Scholar
Ji XM, Ouyang B, Wang CY, Zhang YQ, Jiang T. Wenxiafang, a traditional Chinese college of basic medical sciences, chemotherapeutic resistance in A549/DDP cells by down-regulating expression levels of P-gp, LRP and MRP. Chin Remed Clin (Chin) 2006;6:885–888.
Google Scholar
Bria E, Cuppone F, Cecere FL, Milella M, Nistico C, Cognetti F, et al. Adjuvant chemotherapy for non-small cell lung cancer. J Thorac Oncol 2007;2:S7–S11.
Article
PubMed
Google Scholar
Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589–2597.
CAS
Article
PubMed
Google Scholar
Zhang MC, Hu CP. The molecular mechanism of DDP drug resistance in lung cancer. Int J Respir (Chin) 2006;26:152–155.
Google Scholar
Stewart DJ. Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 2007;63:12–31.
Article
PubMed
Google Scholar
Wang WP, Ji XM, Ouyang B, Wang ZX, Yu HY, Wu ZC. The research of reversing multidrug resistance in lung cancer. World J Integr Tradit West Med (Chin) 2011;6:820–823.
Google Scholar
Meng S, Zhou Z, Chen F, Kong X, Liu H, Jiang K, et al. Newcastle disease virus induces apoptosis in cisplatinresistant human lung adenocarcinoma A549 cells in vitro and in vivo. Cancer Lett 2012;317:56–64.
CAS
Article
PubMed
Google Scholar
Liu XD, Sun H, Liu GT. Tumor chemosensitization strategies based on apoptosis manipulations. Chin Pharmacol Bull (Chin) 2009;25:1261–1264.
CAS
Google Scholar
Ji XM, Ouyang B, Wang CY. Wenxia Formular restrain the multiplication of the A549 cells and the infection to the expression of PCNA, Rb and CyclinD1. Chin Arch Tradit Chin Med (Chin) 2010;28:721–723.
Google Scholar
Ji XM, Ouyang B, Li WH, Wang CY. Effect of Wenxiachangfufang on PCNA, p16 and cyclinD1 in mice with Lewis lung carcinoma. Lishizhen Med Mater Med Res (Chin) 2011;22:96–98.
Google Scholar
Ji XM, Ouyang B, Lui H, Liu GW, Wu ZC, Yu HY, et al. In vitro and in vivo inhibitory effect of the combination of WCF with cisplatin in non-small cell lung cancer. Chin J Integr Med 2011;17:908–916.
Article
PubMed
Google Scholar
Fujii S, Ochiai A. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Sci 2008;99:738–746.
CAS
Article
PubMed
Google Scholar
Cao Q, Yu J, Dhanasekaran SM, Kim JH, Mani RS, Tomlins SA, et al. Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene 2008;27:7274–7284.
CAS
Article
PubMed
PubMed Central
Google Scholar
Dickens LS, Powley IR, Hughes MA, MacFarlane M. The 'complexities' of life and death: death receptor signalling platforms. Exp Cell Res 2012;318:1269–1277.
CAS
Article
PubMed
Google Scholar
Lee EW, Kim JH, Ahn YH, Seo J, Ko A, Jeong M, et al. Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis. Nat Commun 2012;3:978–989.
Article
PubMed
Google Scholar
Abbosh PH, Montgomery JS, Starkey JA, Novotny M, Zuhowski EG, Egorin MJ, et al. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells. Cancer Res 2006;66:5582–5591.
CAS
Article
PubMed
Google Scholar
Hussain M, Rao M, Humphries AE, Hong JA, Liu F, Yang M, et al. Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells. Cancer Res 2009;69:3570–3578.
CAS
Article
PubMed
Google Scholar
Hu S, Yu L, Li Z, Shen Y, Wang J, Cai J, et al. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo. Cancer Biol Ther 2010;10:788–795.
CAS
Article
PubMed
Google Scholar
de Bruyn M, Bremer E, Helfrich W. Antibody-based fusion proteins to target death receptors in cancer. Cancer Lett 2013;332:175–183.
CAS
Article
PubMed
Google Scholar
Ougolkov AV, Bilim VN, Billadeau DD. Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2. Clin Cancer Res 2008;14:6790–6796.
CAS
Article
PubMed
PubMed Central
Google Scholar